Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS

Copyright © 2023 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 250(2023) vom: 31. Mai, Seite 109324
1. Verfasser: LaFon, David C (VerfasserIn)
Weitere Verfasser: Woo, Han, Fedarko, Neal, Azar, Antoine, Hill, Harry, Tebo, Anne E, Martins, Thomas B, Han, MeiLan K, Krishnan, Jerry A, Ortega, Victor E, Barjaktarevic, Igor, Kaner, Robert J, Hastie, Annette, O'Neal, Wanda K, Couper, David, Woodruff, Prescott G, Curtis, Jeffrey L, Hansel, Nadia N, Nahm, Moon H, Dransfield, Mark T, Putcha, Nirupama, SPIROMICS investigators
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Antibodies Immunity Immunoglobulin G Opsonization Streptococcus pneumoniae Antibodies, Bacterial Pneumococcal Vaccines